Blogs

1 in 17 of us will be affected by a rare disease

Alastair Kent

Untitled 112 300x201 1 in 17 of us will be affected by a rare diseaseThe major paradox about rare diseases is that collectively rare diseases are not rare. In fact, 3.5 million people in the UK will be affected by a rare disease at some point in their lives – 1 in 17 of us. To put this into perspective, this represents the entire population of Birmingham, Manchester, Edinburgh, Glasgow, Greater Belfast and Cardiff put together. Despite these considerable numbers, in the past rare diseases have largely been overlooked by health policy makers.

A disease is classed as rare when it affects fewer than 5 in 10,000 of the general population. Some rare diseases are relatively well known; cystic fibrosis, motor neurone disease and muscular dystrophy for example. Few people would recognise majority of the 6,000 rare diseases known to exist from alkaptonuria to zygomycosis, however.

In recognition of the need to raise awareness of rare diseases, in 2008 a cluster of European countries instigated Rare Disease Day on what is itself a “rare day” – the 29th February. Today, four years on, Rare Disease Day is an international event marked across the globe, a feat which is testament to the strong desire of patients and their families to raise awareness of these little known and little understood conditions.

The theme for Rare Disease Day 2012 is “Solidarity” with the slogan “rare but strong together”. This reflects that by uniting behind one common message, the voice of people affected by rare diseases is stronger.

Some people are born with a rare disease. Tragically, many children will not make it to adulthood; for others a rare disease will develop later on in life. Each rare disease has very different symptoms and outcomes. Despite the breadth of rare diseases, patients and carers often face similar problems in terms of access to high quality care, support and treatment.

Diagnosis is a major issue for many people affected by rare diseases. Rare Disease UK has found that almost half of patients have to wait over a year for an accurate diagnosis following the onset of symptoms. Of this 20% waited over 5 years and 12% waited over 10 years. Misdiagnoses, often with a more common condition are also a major problem. Almost half of patients are misdiagnosed and nearly a third are misdiagnosed three or more times. Living without a diagnosis is not only distressing for patients and their families, but it also means that they cannot access appropriate care and treatment (where available).

Once patients receive a diagnosis, they often struggle to find trusted sources of information about a condition that they and any of their family and friends have probably never heard of, or anyone that understands the condition to talk to. Patient organisations are often an important source of information and support to patients, however, there are no relevant organisations dealing with the majority of the 6,000 known rare diseases.

Equally, health professionals struggle to get information on how the conditions should be managed and few care pathways are available. This is aggravated by a lack of scientific knowledge of the disease – often a lack of research means that there will be little understanding about the effects of the disease, or what the outcome for the patient will be. Most rare diseases affect multiple systems of the body and there will be many different health professionals involved in the care of a patient. Poor communication and fragmentation of care can lead to patients bouncing around the system, attending a multitude of different appointments, which is frustrating for patients and carers especially if their needs are not being adequately addressed.

There are no effective treatments for most rare diseases and very few can be cured, nevertheless, patients should be entitled to the best supportive care for their condition. When treatments are available there can be difficulties in access and there are often “postcode lotteries” in access to treatment and good quality care.

Providing a high-quality service to patients with rare diseases is possible, however, and there are numerous examples of world-class services in the UK to prove it. Unfortunately these are currently the exceptions as opposed to the norm. In the UK we now have the opportunity to build on these examples of good practice to address the needs of patients affected by rare diseases in a systematic way. Each country in the European Union has committed to developing a plan to improve service provision as well as facilitating much-needed research into rare diseases. Rare Disease UK has been campaigning vigorously to ensure that this commitment is acted upon in the UK. We hope that by coming together today on Rare Disease Day we can reinforce to the governments and health departments in each of the UK’s four home nations the need for a UK plan to make a real and significant difference to lives of people living with rare diseases and their families.

Alastair Kent OBE, Chair of Rare Disease UK

Tagged in: , , , , , , , ,
  • drbendaniels

    any evidence for this Kawasakiman or did you just read it on a website?

  • kawasakiman

    Do yourself a favour…pick up a few of your household goods, read whats in them, and then find out (using the internet) what the chemicals are, and what they can do.

    (Shampoo is usually a good place to start…)

  • kawasakiman

    True, Mr.Pedantic.

  • julianzzz

    Better to be pedantic than to indulge in hyperbole..

  • kawasakiman

    Overstatement is a tool of communication, whereas being pedantic is an obstruction to efficient communication.

    Also for the record, the word “inhabit” doesn’t explicitly imply life. It can refer simply to existing in a given place.

  • http://twitter.com/actionmedres Action Med Res

    The UK children’s charity Action Medical Research (www.action.org.uk) is marking Rare Diseases Day (29 February) this year by celebrating investing more than £100 million into vital medical research over the last 60 years.

    Thousands of families across the UK are coping with the challenge of caring for a child with a rare and devastating disease for which there is no cure. We know that medical research can save and change children’s lives. Yet surprisingly, medical research into conditions that devastate children’s lives is poorly funded.

    Action Medical Research brings hope to these forgotten families by supporting research for genetic factors that cause distressing and disabling rare conditions.

    http://www.action.org.uk

  • http://twitter.com/actionmedres Action Med Res

    Each year, Action Medical Research awards prestigious grants to help the brightest and best doctors and scientists develop their career in medical research. Mr David Wilkinson was awareded a grant of £139,980 in 2011 to fund his two-year laboratory study into the possibility of using stem cells to treat Hirschsprung’s disease that can threaten babies’ lives.

    http://bit.ly/AqfHZY

  • jameslenton

    One in 17 is not, therefore, “rare”

  • Halfassedmonkeyboy

    It isn’t free you’re right. It is however free at point of use. This means if you get sick you get treatment. We pay for it through a deduction from wages (not a large one) made by the HMRC (tax office). I have a chronic progressive disease and my treatment costs me nothing in a cash money sense. I don’t need insurance from an employer. Go ahead and tell me that the US system is better than ours.

  • Guest

    The reality is, there’s plenty of insurance, while unemployed. Firstly through COBRA and secondly through individual schemes. Unfortunately, most people don’t budget properly.

    I get paid 30% more than I would get in the UK and most of my bills are about 20% less than the UK – I’m a consultant, and I have learned to save for insurance costs. Most don’t.

    If people budget correctly, there are few problems.


Property search
Browse by area

Latest from Independent journalists on Twitter